About Alex

Alex Grosvenor is a Senior Vice President at PRECISIONadvisors, where he leads the EU arm of the Global Pricing Market Access, Pricing & Analytics practice. Alex is based in London and brings more than 10 years’ consulting experience in the biopharmaceutical industry, seven of these in pricing and market access (P&MA).

Prior to joining Precision, Alex was a Senior Director in the Pricing and Market Access practice for ICON plc (formerly PriceSpective), based in London. During his time at ICON, he developed a particular expertise in orphan indications and, more recently, cell and gene therapies, working on some of the industry’s most innovative new treatments.

Alex has also worked extensively in the areas of oncology, biosimilars, cardiovascular, CNS, HIV, multiple sclerosis, and ophthalmology. He has deep experience across a broad range of P&MA projects, with specific knowledge in the European markets, international price referencing risks, launch sequencing, cross-indication pricing and global launch pricing.

Before ICON, Alex was a Project Director at Apex Healthcare Consulting, a consultancy providing commercial and strategic evaluations for biopharmaceutical companies in speciality markets. Before Apex, Alex worked at Wood Mackenzie, an Edinburgh-based firm providing research and consulting services to the life sciences industry. Alex holds a BSc (Hons) degree in Biochemistry from the University of St Andrews.